| Expression pattern: |
DN |
| Associated gene: |
HSP27 |
| Associated microRNA: |
- |
| Biological function: |
Inhibits GBM cell proliferation and invasion, affects cytoskeleton organization, and suppresses tumor growth in an intracranial xenograft model. |
| Molecular mechanism: |
hsa_circ_0072309 inhibits GBM proliferation and invasion by downregulating HSP27; the exact upstream mechanism of HSP27 downregulation was not clarified. |
| Biological pathway or process: |
proliferation (inhibits); invasion (inhibits); migration (inhibits); EMT (inhibits); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Transfection; EdU Staining; Wound Healing Assay; Transwell Assay; Western Blot; IF (Immunofluorescence); IHC (Immunohistochemistry); H&E Staining; In Vivo Animal Model |
| Clinical significance: |
hsa_circ_0072309 may act as a potential therapeutic target for GBM comprehensive treatment. |
| Description: |
hsa_circ_0072309 is downregulated in GBM/glioma tissues compared with non-tumor brain tissues. Functionally, it suppresses GBM cell proliferation and invasion in vitro and reduces tumor growth in an intracranial U87 xenograft model. Mechanistically, the study links its tumor-suppressive effects to downregulation of HSP27 and changes in cytoskeleton/EMT-related markers. |
| Confidence score: |
0.622 |